<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30359480</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>25</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1097-0142</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>25</Day>                    </PubDate>                </JournalIssue>                <Title>Cancer</Title>                <ISOAbbreviation>Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.31825</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Clips are often placed to mark axillary nodes with biopsy-confirmed metastases in patients with breast cancer. The evaluation of clipped nodes after chemotherapy can identify patients who have eradication of nodal disease. The goal of this study was to determine whether preoperative fine-needle aspiration (FNA) of clipped nodes after neoadjuvant chemotherapy (NAC) could predict the presence of residual disease.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">This prospective registry study enrolled 50 patients with a clip placed to mark nodes with biopsy-confirmed metastases who had completed NAC. Participants underwent FNA of the clipped node before seed-localized lymph node excision. FNA pathology was compared with surgical pathology.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 36 patients (72%) with residual disease on surgical pathology: 3 (8%) had a nondiagnostic aspirate, carcinoma was seen in 14 (39%), and 19 (53%) had a false-negative result. The sensitivity of FNA was 42.4%, its specificity was 100%, and its negative predictive value was 40.6%. In a univariate analysis, the odds of a true-positive result increased significantly with the mean initial size of the clipped node (odds ratio [OR], 4.3; P = .004) and the size of the metastatic focus after NAC (OR, 1.3; P = 0.003), whereas normalization of nodes after chemotherapy (OR, 0.1) and a lack of response on ultrasound (OR, 0.11) were associated with a false-negative result (P = .01).</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FNA of marked nodes after chemotherapy has a high false-negative rate. This highlights the need for surgical staging of the axilla after NAC to assess the response.</AbstractText>                <CopyrightInformation>Â© 2018 American Cancer Society.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Caudle</LastName>                    <ForeName>Abigail S</ForeName>                    <Initials>AS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kuerer</LastName>                    <ForeName>Henry M</ForeName>                    <Initials>HM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Krishnamurthy</LastName>                    <ForeName>Savitri</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shin</LastName>                    <ForeName>Kyungmin</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hobbs</LastName>                    <ForeName>Brian P</ForeName>                    <Initials>BP</Initials>                    <AffiliationInfo>                        <Affiliation>Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ma</LastName>                    <ForeName>Junsheng</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mittendorf</LastName>                    <ForeName>Elizabeth A</ForeName>                    <Initials>EA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Washington</LastName>                    <ForeName>Ashley C</ForeName>                    <Initials>AC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>DeSnyder</LastName>                    <ForeName>Sarah M</ForeName>                    <Initials>SM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Black</LastName>                    <ForeName>Dalliah M</ForeName>                    <Initials>DM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hunt</LastName>                    <ForeName>Kelly K</ForeName>                    <Initials>KK</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Wei T</ForeName>                    <Initials>WT</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>CA016672</GrantID>                    <Agency>NIH P30</Agency>                    <Country/>                </Grant>                <Grant>                    <Agency>Mike Hogg Foundation</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>CA16672</GrantID>                    <Agency>NIH Cancer Center Support Grant</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>25</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Cancer</MedlineTA>            <NlmUniqueID>0374236</NlmUniqueID>            <ISSNLinking>0008-543X</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">chemotherapy</Keyword>            <Keyword MajorTopicYN="N">fine-needle biopsy</Keyword>            <Keyword MajorTopicYN="N">lymph nodes</Keyword>            <Keyword MajorTopicYN="N">surgery</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>08</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30359480</ArticleId>            <ArticleId IdType="doi">10.1002/cncr.31825</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>